Kidney Disease

Higher levels of psychological flexibility were associated lower prevalence and incidence of depression among patients who had chronic kidney disease and were treated with peritoneal dialysis, hemodialysis or no dialysis.

The National Kidney Foundation and the American Society of Nephrology are asking CMS for detailed information on the outcomes of patients with kidney disease who have contracted COVID-19.

Kidney Disease: Improving Global Outcomes has published a practice guideline for diabetes management in patients with chronic kidney disease.

Like most nephrology meetings taking place this year, the American Society of Nephrology’s annual symposia – Kidney Week – will be offered as a fully digital conference. This year’s program takes place Oct. 22-25, with early programs starting Oct. 19.

Following an announcement that its dialysis facilities will be joining a data exchange network to improve patient care coordination, Fresenius Medical Care North America has expanded its partnership with Humana to further these efforts.

A study of patients who were hospitalized with COVID-19 showed those with pre-existing kidney disease experienced worse outcomes, including increased mortality.

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for dialysis at Indiana University Health in Indianapolis, discussed treatment approaches for patients at risk for cardiovascular complications.

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for dialysis at Indiana University Health in Indianapolis, spoke with Healio on the relationship between anemia and quality of life in patients with chronic kidney disease.

The value of precision medicine has been shown with the identification of the genetic causes of tumors that differ among patients. Applied to nephrology, precision medicine can offer an earlier look at the potential risk for kidney disease.

Cannabis has been long misunderstood as a dangerous narcotic by federal regulators and has medicinal value for patients with chronic kidney disease, a speaker at the American Nephrology Nurses Association’s National Symposium said.